3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Rituximab
689
Cyclophosphamide
616
Vincristine
286
Etoposide
272
Doxorubicin
272
Cytarabine
231
Prednisone
229
Methotrexate
222
fludarabine phosphate
189
Filgrastim
187
Dexamethasone
181
fludarabine
176
Lenalidomide
165
Radiotherapy
128
Melphalan
127
Peripheral Blood Stem Cell Transplantation
123
Busulfan
118
Bendamustine Hydrochloride
116
Granulocyte Colony-Stimulating Factor
113
Bortezomib
112
ibrutinib
111
Mycophenolic Acid
110
venetoclax
106
Whole-Body Irradiation
106
obinutuzumab
105
Tacrolimus
105
Gemcitabine
92
zanubrutinib
82
Specimen Handling
82
Cyclosporine
76
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
AIEOP acute lymphoblastic leukemia protocol
×
Lymphoid
×
Clear all
NCT06184009
2025-06-08
HR ALL
Seoul St. Mary's Hospital
Phase 2
Recruiting
370 enrolled